Pascal Neuville
Fondateur chez Peptimimesis SAS
Provenance du réseau au premier degré de Pascal Neuville
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
15
| Public Company | Biotechnology | 15 |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France.
13
| Holding Company | Biotechnology | 13 |
Axilum Robotics SAS
 Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Find Therapeutics
 Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada.
6
| Holding Company | Biotechnology | 6 |
Mavalon Therapeutics Ltd.
 Mavalon Therapeutics Ltd. Medical SpecialtiesHealth Technology Mavalon Therapeutics Ltd. develops orally available small molecule able to induce glial cell line-derived neurotropic factor production within the brain of parkinson’s patients. The company is headquartered in Hatfield, the United Kingdom.
1
| Holding Company | Medical Specialties | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Pascal Neuville via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| TOTALENERGIES SE | Integrated Oil | Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| APRIL | Insurance Brokers/Services | Director/Board Member | |
| STALLERGENES | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Director/Board Member Public Communications Contact Sales & Marketing | |
| McGill University | College/University | Doctorate Degree Doctorate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
TSGH SAS
 TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Financial Conglomerates | Chief Executive Officer Chairman | |
| University of Montréal | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Echosens SA
 Echosens SA Medical SpecialtiesHealth Technology Echosens SA engages in the manufacture of medical imaging equipment. It focuses on developing FibroScan. The company was founded by Laurent Sandrin and Sylvain Yon on June 20, 2001 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| MEDIAN TECHNOLOGIES | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree Graduate Degree | |
| HEC Montréal | College/University | Masters Business Admin Masters Business Admin | |
| ESSEC Business School | College/University | Undergraduate Degree Masters Business Admin | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Strasbourg | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
Demeter Partners SA
 Demeter Partners SA Investment ManagersFinance Demeter Partners SA (Demeter Partners) is a French private equity firm which was founded in 2005 by Sophie Paturle-Guesnerot and Stéphane Villecroze and is majority-owned by the management team. Headquartered in Paris with an additional office in Madrid, Demeter Partners has partnerships with English, German and Spanish funds which are involved in their sectors and are also members of international networks of investors specialized in 'clean technologies'. The firm manages the Demeter Fund, sponsored by the Caisse des Dépôts (CDC Entreprises) and the Institut Français du Pétrole (French Petroleum Institute) for institutional investors including life insurance companies, health insurance companies, pension funds and sophisticated private investors. | Investment Managers | Director/Board Member | |
| University of Nice Sophia Antipolis | College/University | Doctorate Degree Graduate Degree | |
Advanced BioScience Laboratories, Inc.
 Advanced BioScience Laboratories, Inc. Medical/Nursing ServicesHealth Services Advanced BioScience Laboratories, Inc. provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. It focuses on the development of therapeutics, vaccines, and other biologic products. The company was founded in 1961 and is headquartered in Rockville, MD. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| University of Lyon | College/University | Doctorate Degree Doctorate Degree | |
| Merieux Group | Corporate Secretary | ||
Silliker Group Corp. SARL
 Silliker Group Corp. SARL Miscellaneous Commercial ServicesCommercial Services Silliker Group Corp. SARL operates as holding firm with interest in food testing and consulting network. The company was founded in 2008 and is headquartered in Tassin-la-Demi-Lune, France | Miscellaneous Commercial Services | Director/Board Member | |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Biotechnology | Corporate Officer/Principal Chief Executive Officer Corporate Secretary | |
Association Lyon Place Financière
 Association Lyon Place Financière Miscellaneous Commercial ServicesCommercial Services Association Lyon Place Financière et Tertiaire operates as a business consortium, with interest in the promotion of regional financial development. Its advocacies cover the monitoring of competitivenes, risk, equity, shareholder relations, investment, and transparency. The company was founded by Roger Michaux, Raymond Barre, Régis Lagrevol, and Etienne Subra in 1986 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Synergie Lyon Cancer
 Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | Director/Board Member President | |
Lyon Pôle Bourse
 Lyon Pôle Bourse Financial ConglomeratesFinance Lyon Pôle Bourse engages in the provision of regional economy development services. The company was founded in 2009 and is headquartered in Lyon, France. | Financial Conglomerates | Director/Board Member | |
Platine Pharma Services SAS
 Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
 Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| ELSALYS BIOTECH | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder | |
| GENEURO SA | Biotechnology | Director/Board Member Director/Board Member | |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kaerus Bioscience France SASU
 Kaerus Bioscience France SASU Miscellaneous Commercial ServicesCommercial Services Kaerus Bioscience France SASU engages in research and development in biotechnology. The company was founded on February 23, 2017 and is headquartered in Orléans, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
Yukin Therapeutics SAS
 Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Yukin Therapeutics SAS manufactures pharmaceutical preparations. The company was founded by Matthieu Coutet on June 29, 2018 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
adMare Bioinnovations
 adMare Bioinnovations adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Director/Board Member Chief Tech/Sci/R&D Officer | ||
Villaris Therapeutics, Inc.
 Villaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Villaris Therapeutics, Inc. is an asset-centric biopharmaceutical company. The company is based in Cary, NC. The company was founded in 2019 by John Harris. The CEO is Andrea Epperly. | Pharmaceuticals: Major | Director/Board Member | |
| Pearl River Bio GmbH | Director/Board Member | ||
| Pega-One SAS | Director/Board Member | ||
| Medicxi Ventures (Jersey) Ltd. (Switzerland) | Corporate Officer/Principal | ||
| Nira Biosciences, Inc. | Director/Board Member | ||
| ALDENA THERAPEUTICS, INC. | Director/Board Member | ||
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Vimela Therapeutics Ltd. | Director/Board Member | ||
Polyplus-transfection SA
 Polyplus-transfection SA BiotechnologyHealth Technology Polyplus-transfection SA develops and sells solutions for the delivery of nucleic acids in research, bio production, and therapeutics. Its products are transfection reagents and trademarks, mainly for gene and cell therapies. The company was founded by Jean-Paul Behr, Anne-Lise Monjanel, Joelle Bloch, and Patrick Metz in January 2001 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| France | 33 |
| Canada | 7 |
| Etats-Unis | 6 |
| Royaume-Uni | 3 |
| Suisse | 3 |
Sectorielle
| Health Technology | 18 |
| Consumer Services | 10 |
| Commercial Services | 7 |
| Finance | 6 |
| Health Services | 4 |
Opérationnelle
| Director/Board Member | 222 |
| Chairman | 71 |
| Corporate Officer/Principal | 64 |
| Chief Executive Officer | 32 |
| Independent Dir/Board Member | 31 |
Relations les plus connectées
| Insiders | |
|---|---|
| Thierry Marraud | 50 |
| Michèle Ollier | 40 |
| François Thomas | 25 |
| Jean Bizzari | 24 |
| Jonathan Treherne | 24 |
| Philippe Archinard | 24 |
| Louis Joseph Nisbet | 24 |
| Bernard Daugeras | 23 |
| Dominique Takizawa | 23 |
| Paul Truex | 17 |
| Youssef Bennani | 17 |
| Margaret Liu | 15 |
| Sébastien Groyer | 15 |
| Michel Dubois | 12 |
| Georges Hibon | 10 |
- Bourse
- Insiders
- Pascal Neuville
- Connexions Sociétés
